Tandem vs Single Autologous Stem Cell Transplant and Event-Free Survival in High-Risk Neuroblastoma
This randomized trial compares the effect of intensification of consolidation therapy using sequential or “tandem” vs single autologous transplant after induction therapy on event-free survival among children and young adults with high-risk neuroblastoma.
Source: JAMA - Category: General Medicine Source Type: research
More News: Brain | Children | General Medicine | Neuroblastoma | Neurology | Stem Cell Therapy | Stem Cells | Transplants